TriVascular Technologies Competitors and Similar CompaniesClear all

TriVascular Technologies's competitors and similar companies include MyMD Pharmaceuticals, Natus Medical, Notal Vision and Revenio.

	TriVascular Technologies TriVascular has pioneered numerous design and manufacturing technologies in pursuit of our commitment to providing optimal solutions for endovascular aortic repair (EVAR).	MyMD Pharmaceuticals MyMD Pharmaceuticals (formerly known as Akers Biosciences) is a clinical-stage pharmaceutical company.	Natus Medical Natus Medical is a company focused on neurodiagnostic and newborn care technologies.	Notal Vision Notal Vision is an ophthalmic diagnostic services company.	Revenio Revenio designs, manufactures, and sells medical instruments used for measuring intraocular pressure and bone density.
Founding Date	Founding Date 1998	Founding Date 2014	Founding Date 1987	Founding Date 2000	Founding Date 2001
Type	Type Subsidiary	Type Public	Type Private	Type Private	Type Public
Tags	Tags Healthcare Manufacturing & Industrial healthtech medical devices medical diagnostics	Tags Healthcare Manufacturing & Industrial healthtech medical devices medical diagnostics	Tags Healthcare medical devices medical diagnostics medtech	Tags Healthcare Manufacturing & Industrial healthtech medical devices medical diagnostics	Tags Healthcare Manufacturing & Industrial clinics healthtech medical devices medical diagnostics
Locations	Locations Irvine, US HQ Rosmalen, NL	Locations West Deptford, US HQ	Locations Middleton, US HQ Silverwater, AU Oakville, CA Shanghai, CN Taastrup, DK Massy, FR Mérignac, FR see more	Locations HQ	Locations Vantaa, FI HQ
Employees	Employees 43	Employees 32	Employees 1,4001% decrease	Employees 86	Employees 246
Valuation ($)	Valuation ($) N/A	Valuation ($) 4.3 m	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) 914.9 m
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) $473.4m (FY, 2021)	Revenue (est.) N/A	Revenue (est.) €109.7m (FY, 2025)
Cost of goods	Cost of goods N/A	Cost of goods N/A	Cost of goods $193m (FY, 2021)	Cost of goods N/A	Cost of goods €31.9m (FY, 2025)
Gross profit	Gross profit N/A	Gross profit N/A	Gross profit $273.7m (FY, 2021)	Gross profit N/A	Gross profit €78m (FY, 2025)
Net income	Net income N/A	Net income ($11.6m) (FY, 2025)	Net income $13.2m (FY, 2021)	Net income N/A	Net income €17.4m (FY, 2025)